Lorna Ewart's Biography

Lorna Ewart, Global Strategy Lead, AstraZeneca

Lorna obtained an honours degree in Pharmacology from the University of Aberdeen and a PhD from Sir John Vane’s William Harvey Research Institute, University of London. She joined the Respiratory and Inflammation research area within AstraZeneca as a lead biologist bringing forward projects to candidate drug nomination before moving into pre-clinical drug safety to lead a safety pharmacology team delivering across multiple therapeutic areas. Lorna spent two years in Gothenburg, Sweden as the therapy area lead toxicologist for Respiratory and Inflammation therapy area before returning to Cambridge, UK where she heads the Centre of Excellence for Microphyisological Systems within AstraZeneca’s Innovative Medicines Unit. Here she has established strategic collaborations with leading external academics as well as ensured technology transfer into AstraZeneca. Scientifically, Lorna is passionate about the translation of preclinical science to patient outcome. She has over 25 peer reviewed publications and is a fellow of the Royal Society of Biology and the British Pharmacological Society.